Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kyowa Kirin
Pharma
Trump's tariffs, Leqembi, Kyowa Kirin—Fierce Pharma Asia
U.S. pharma tariffs are expected "in the next months or two." Leqembi won approval in the EU. Kyowa Kirin completed a biologics plant. And more.
Angus Liu
Apr 18, 2025 9:25am
Kyowa Kirin wraps up build out of $118M biologics plant
Apr 11, 2025 10:00am
Orchard names commercial chief for world’s most expensive drug
Feb 12, 2025 11:40am
Merck, AstraZeneca, Astellas—Fierce Pharma Asia
Feb 7, 2025 9:00am
BMS, Kyowa Kirin layoffs hit 119 in New Jersey
Feb 4, 2025 2:02pm
China cuts, CSL site closure and Kyowa deal—Fierce Pharma Asia
Nov 22, 2024 3:00am
.jpg?VersionId=lqZY4CDGUvkKYC1pRIqZC.ztWXOzQzvk)
